Effect of HIV Infection and Antiretroviral Treatment on Pregnancy Rates in the Western Cape Province of South Africa.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
11 06 2020
Historique:
received: 12 02 2019
accepted: 09 07 2019
pubmed: 25 7 2019
medline: 20 2 2021
entrez: 24 7 2019
Statut: ppublish

Résumé

Previous studies suggest that untreated human immunodeficiency virus (HIV) infection is associated with a reduced incidence of pregnancy, but studies of the effect of antiretroviral treatment (ART) on pregnancy incidence have been inconsistent. Routine data from health services in the Western Cape province of South Africa were linked to identify pregnancies during 2007-2017 and maternal HIV records. The time from the first (index) pregnancy outcome date to the next pregnancy was modeled using Cox proportional hazards models. During 2007-2017, 1 042 647 pregnancies were recorded. In all age groups, pregnancy incidence rates were highest in women who had started ART, lower in HIV-negative women, and lowest in ART-naive HIV-positive women. In multivariable analysis, after controlling for the most recent CD4+ T-cell count, pregnancy incidence rates in HIV-positive women receiving ART were higher than those in untreated HIV-positive women (adjusted hazard ratio, 1.63; 95% confidence interval, 1.59-1.67) and those in HIV-negative women. Among women who have recently been pregnant, receipt of ART is associated with high rates of second pregnancy. Better integration of family planning into HIV care services is needed.

Sections du résumé

BACKGROUND
Previous studies suggest that untreated human immunodeficiency virus (HIV) infection is associated with a reduced incidence of pregnancy, but studies of the effect of antiretroviral treatment (ART) on pregnancy incidence have been inconsistent.
METHODS
Routine data from health services in the Western Cape province of South Africa were linked to identify pregnancies during 2007-2017 and maternal HIV records. The time from the first (index) pregnancy outcome date to the next pregnancy was modeled using Cox proportional hazards models.
RESULTS
During 2007-2017, 1 042 647 pregnancies were recorded. In all age groups, pregnancy incidence rates were highest in women who had started ART, lower in HIV-negative women, and lowest in ART-naive HIV-positive women. In multivariable analysis, after controlling for the most recent CD4+ T-cell count, pregnancy incidence rates in HIV-positive women receiving ART were higher than those in untreated HIV-positive women (adjusted hazard ratio, 1.63; 95% confidence interval, 1.59-1.67) and those in HIV-negative women.
CONCLUSION
Among women who have recently been pregnant, receipt of ART is associated with high rates of second pregnancy. Better integration of family planning into HIV care services is needed.

Identifiants

pubmed: 31332437
pii: 5532045
doi: 10.1093/infdis/jiz362
pmc: PMC7289540
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1953-1962

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD080465
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

AIDS Behav. 2009 Jun;13 Suppl 1:12-9
pubmed: 19301116
Contraception. 2011 May;83(5):397-404
pubmed: 21477680
J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):439-45
pubmed: 16010167
AIDS. 2017 Apr;31 Suppl 1:S69-S76
pubmed: 28296802
BMC Health Serv Res. 2018 Feb 27;18(1):140
pubmed: 29482587
Obstet Gynecol. 2004 Apr;103(4):663-8
pubmed: 15051556
AIDS. 2000 Dec 1;14(17):2741-50
pubmed: 11125893
AIDS. 2016 Aug 24;30(13):2099-105
pubmed: 27163708
PLoS One. 2012;7(4):e36039
pubmed: 22558319
J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):477-83
pubmed: 18209677
Lancet. 1998 Jan 10;351(9096):98-103
pubmed: 9439494
AIDS Behav. 2009 Jun;13 Suppl 1:38-46
pubmed: 19343492
Sex Transm Infect. 2010 Dec;86 Suppl 2:ii22-7
pubmed: 21106511
AIDS. 2004 Jan 23;18(2):281-6
pubmed: 15075546
AIDS. 1998;12 Suppl 1:S41-50
pubmed: 9677188
J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S218-27
pubmed: 25436821
Bull World Health Organ. 2005 Jul;83(7):489-94
pubmed: 16175822
PLoS Med. 2010 Feb 09;7(2):e1000229
pubmed: 20161723
AIDS Behav. 2009 Jun;13 Suppl 1:28-37
pubmed: 18389364
AIDS. 2005 Mar 4;19(4):443-5
pubmed: 15750400
AIDS. 2004 Jun;18 Suppl 2:S35-43
pubmed: 15319742
Cochrane Database Syst Rev. 2016 Aug 09;(8):CD010243
pubmed: 27505053
Trop Med Int Health. 2016 Sep;21(9):1071-85
pubmed: 27371942
J Acquir Immune Defic Syndr. 2013 May 1;63(1):e33-5
pubmed: 23574927
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):324-32
pubmed: 26910499
Lancet HIV. 2015 Nov;2(11):e474-82
pubmed: 26520927
AIDS. 2017 Apr;31 Suppl 1:S5-S11
pubmed: 28296796
AIDS. 2019 Mar 1;33(3):483-491
pubmed: 30531313
AIDS Res Treat. 2011;2011:519492
pubmed: 21490780
AIDS. 2004 Mar 26;18(5):799-804
pubmed: 15075516
BMJ Open. 2018 Apr 3;8(4):e019979
pubmed: 29615449
N Engl J Med. 2018 Sep 6;379(10):979-981
pubmed: 30037297
BMJ Glob Health. 2018 Apr 24;3(Suppl 2):e000565
pubmed: 29713507
Am J Public Health. 2011 Feb;101(2):350-8
pubmed: 20403884
AIDS. 2015 Sep 10;29(14):1845-53
pubmed: 26372390
Epidemiol Health. 2017 Jul 16;39:e2017028
pubmed: 28728348
J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):411-418
pubmed: 27243903
South Afr J HIV Med. 2017 Jul 28;18(1):695
pubmed: 29568631
Clin Infect Dis. 2014 Nov 15;59(10):1483-94
pubmed: 25091305
AIDS Behav. 2013 Feb;17(2):471-8
pubmed: 22354359

Auteurs

Leigh F Johnson (LF)

Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.

Themba Mutemaringa (T)

Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Department of Health, Provincial Government of the Western Cape, Cape Town, South Africa.

Alexa Heekes (A)

Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Department of Health, Provincial Government of the Western Cape, Cape Town, South Africa.

Andrew Boulle (A)

Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Department of Health, Provincial Government of the Western Cape, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH